The change in Wnt effectors is likely an important driver of tumour-specific gene expression, as TCF/LEF binding motifs are enriched in tumour-specific active chromatin, and given that Lef1/Tcf7 are mostly transcriptional activators while Tcf7l1 is known to have mainly repressive functions. The gene discussed is TCF7L1; the disease is neoplasm.